Pictet Asset Management (Switzerland)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $73.5M | Sell |
2,252,206
-18,185
| -0.8% | -$593K | 0.09% | 240 |
|
|
2023
Q1 | $79.9M | Buy |
2,270,391
+5,079
| +0.2% | +$179K | 0.1% | 226 |
|
|
2022
Q4 | $104M | Buy |
2,265,312
+109,947
| +5% | +$5.04M | 0.15% | 184 |
|
|
2022
Q3 | $104M | Sell |
2,155,365
-52,523
| -2% | -$2.54M | 0.15% | 182 |
|
|
2022
Q2 | $86.7M | Sell |
2,207,888
-342,175
| -13% | -$13.4M | 0.12% | 211 |
|
|
2022
Q1 | $93.9M | Sell |
2,550,063
-54,734
| -2% | -$2.01M | 0.11% | 221 |
|
|
2021
Q4 | $119M | Buy |
2,604,797
+214,005
| +9% | +$9.75M | 0.12% | 207 |
|
|
2021
Q3 | $83M | Buy |
+2,390,792
| New | +$83M | 0.09% | 251 |
|